Gender differences in epidemiological factors associated with treatment completion status of leprosy patients in the most hyperendemic district of Nepal

Southeast Asian Journal of Tropical Medicine and Public Health

Volumn 35, Issue 2, 2004, Pages 334-339

  Rajendra Kumar, B C ^a,f   Singhasivanon, Pratap ^a   Sherchand, Jeevan Bahadur ^b   Mahaisavariya, Punkae ^c   Kaewkungwal, Jaranit ^a   Peerapakorn, Somchai ^d   Mahotarn, Krisada ^e  

^a MAHIDOL UNIVERSITY   (Thailand)

^b TRIBHUVAN UNIVERSITY   (Nepal)

^c MAHIDOL UNIVERSITY   (Thailand)

^d Natl Salmonella and Shigella Centre   (Thailand)

^e MINISTRY OF PUBLIC HEALTH   (Thailand)

^f Norway   (Nepal)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ANALYTIC METHOD; ARTICLE; CHI SQUARE DISTRIBUTION; CONTROLLED STUDY; ENDEMIC DISEASE; FEMALE; FISHER EXACT TEST; HUMAN; LEPROSY; MAJOR CLINICAL STUDY; MALE; NEPAL; PATIENT COMPLIANCE; PATIENT SELECTION; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME;

EID: 4544356363     PISSN: 01251562     EISSN: 26975718     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Garner P, Volmink J. Systematic review of randomized controlled trials of strategies to promote adherence to tuberculosis treatment. Br Med J 1997; 315: 1403-6.
2. Griffiths S, Ready N. Defaulting patterns in a provincial leprosy control program in Northern Mozambique. Lepr Rev 2001; 72: 199-205.
3. Guocheng Z, Wenzhong L, Liangbin Y, et al. An epidemiological survey of deformities and disabilities among 14,257 cases of leprosy in 11 countries. Lepr Rev 1993; 64: 143-9.
4. Heynders ML, Meijs JJ, Anderson AM. Towards an understanding of non-compliance. An assessment of risk factors for defaulting from leprosy treatment. Lepr Rev 2000; 71: 369-76.
5. His Majesty's Government - Ministry of Health, Nepal. Annual report, 2001/2002.
6. Iyere BB. Leprosy deformities: experience in Molai leprosy hospital, Maiduguri, Nigeria. Lepr Rev 1990; 61: 171-79.
7. Mull JD, Wood CS, Gans LP, Mull DS. Culture and 'compliance' among leprosy patients in Pakistan. Soc Sci Med 1989; 29: 799-811.
8. Myint T, Htoon MT, Win M, Yin C. Risk factors among defaulter in the urban leprosy control center of Thaketa township in the city of Yangon, Myanmar. Lepr Rev 1992; 63: 345-9.
9. Ponnighaus IM, Boerrigter G, Fine PEM, Ponnighaus JM, Russell J. Disabilities in leprosy patients ascertained in a total population survey in Karonga district, Northern Malawi. Lepr Rev 1990; 61: 366-74.
10. Premkumar R, Dave SL. Impact of multidrug therapy on health personnel in their level of job satisfaction. Ind J Lepr 1993; 65: 429-38.
11. Rao SP, Subramanian M, Subramanian G. Deformity incidence in leprosy patients treated with multidrug therapy. Ind J Lepr 1994; 66: 449-54.
12. Sana SP, Das KK. Disability pattern among leprosy cases in an urban area (Calcutta). Ind J Lepr 1993; 65: 305-14.
13. Schafer J. Leprosy and disability control in the Guera Prefecture of Chad, Africa: do women have access to leprosy control services? Lepr Rev 1998; 69: 267-78.
14. Tiendrebeogo A, Toure I, Zerbo PJ. A survey of leprosy impairments and disabilities among patients treated by MDT in Burkina Faso. Int J Lepr 1996; 64: 15-25.
15. Ulrich M, Zulueta AM, Caceres-Dittmar G, Pinardi ME, Rada EM, Aranzuazu N. Leprosy in women: characteristics and repercussions. Soc Sci Med 1993; 37: 445-56.
16. White C. Socio-cultural considerations in the treatment of leprosy in Rio de Janeiro, Brazil. Lepr Rev 2002; 73: 356-65.
17. WHO. A guide to eliminate leprosy as public health problem. Pocket edition. 1997: 61.
18. WHO, Report of a consultative meeting on leprosy elimination campaigns. WHO/LEP/99.3, 1999.
19. Xiang-Sheng C, Gan-Yun Y, Cheng J, et al. An investigation of attitudes, belief and behavior of leprosy patients, family members and PHC workers towards multidrug therapy in Yangzhou and Dongtai districts of China. Lepr Rev, 1997; 68: 155-61.